BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2548179)

  • 1. A malignant tumor of the pancreas producing glucagonoma syndrome: coexistence of glucagon and pancreatic polypeptide (PP) in the tumor cells.
    Bani D; Bani Sacchi T; Biliotti G
    Pancreas; 1989; 4(4):511-9. PubMed ID: 2548179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A human pancreatic glucagonoma, ultrastructural, immunocytochemical and radioimmunological investigations (author's transl)].
    Voigt JJ; Hollande E; Pradayrol L; Vinel JP; Gorguet B
    Ann Pathol; 1981; 1(4):287-97. PubMed ID: 6274365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A malignant tumor of the pancreas producing glucagonoma syndrome: immunocytochemistry and ultrastructure of liver metastases and comparison with the primary tumor.
    Bani D; Bani Sacchi T; Biliotti G
    Pancreas; 1989; 4(4):492-5. PubMed ID: 2548178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electron microscopic and immunoelectron microscopic demonstration of pancreatic polypeptide cells in glucagonoma: colocalization of pancreatic peptide and glucagon in single secretory granules.
    Ooi A; Katsuda S; Nakanishi I; Kameya T; Yamaguchi K; Kitamura H; Hayakawa Y
    Ultrastruct Pathol; 1989; 13(1):15-22. PubMed ID: 2537546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucagonomas. Ultrastructure and immunocytochemistry.
    Warner TF; Block M; Hafez GR; Mack E; Lloyd RV; Bloom SR
    Cancer; 1983 Mar; 51(6):1091-6. PubMed ID: 6295622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunocytochemical characterization of 10 pancreatic tumours, associated with the glucagonoma syndrome, using antibodies to separate regions of the pro-glucagon molecule and other neuroendocrine markers.
    Hamid QA; Bishop AE; Sikri KL; Varndell IM; Bloom SR; Polak JM
    Histopathology; 1986 Feb; 10(2):119-33. PubMed ID: 3007321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The glucagonoma syndrome, its place among endocrine tumours of the pancreas. A case report with histoimmunological and ultrastructural studies (author's transl)].
    Le Bodic MF; Le Bodic L; Blavon-Duchesne N; Kergaravat JL; Le Duigou D; Riet Y; Lefranc G; Mussini-Montpellier J
    Arch Anat Cytol Pathol; 1981; 29(6):338-44. PubMed ID: 6275804
    [No Abstract]   [Full Text] [Related]  

  • 8. Morphological changes in the human endocrine pancreas induced by chronic excess of endogenous glucagon.
    Bani D; Biliotti G; Sacchi TB
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1991; 60(3):199-206. PubMed ID: 1679271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular and cellular analysis of a neoplastic pancreatic A cell tumor.
    Drucker DJ; Asa SL; Silverberg J; Brubaker PL
    Cancer; 1990 Apr; 65(8):1762-70. PubMed ID: 1969326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic polypeptide in islet cell tumors. Morphologic and functional correlations.
    Tomita T; Kimmel JR; Friesen SR; Doull V; Pollock HG
    Cancer; 1985 Oct; 56(7):1649-57. PubMed ID: 2992743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secretory granules in benign and malignant glucagonomas of the pancreas.
    Nakanishi I; Katsuda S; Kajikawa K; Yonemura Y; Konishi K; Miwa K
    Acta Pathol Jpn; 1984 Jan; 34(1):95-102. PubMed ID: 6328864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A postmortem study of malignant glucagonoma with heart muscle hypertrophy, including chemical, histochemical, immunohistological and ultrastructural observations.
    Takemiya M; Miyayama H; Takeya M; Takeuchi T; Konno T; Kitoh M; Fukushima H
    Hum Pathol; 1981 Nov; 12(11):988-99. PubMed ID: 6274784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Islet cell tumor.
    Fitzpatrick B; Ordoñez NG; Mackay B
    Ultrastruct Pathol; 1991; 15(4-5):579-84. PubMed ID: 1684455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hyperplasia of the glucagon-producing cells of the pancreas (the glucagonoma syndrome)].
    Saenko VF; Belianskiĭ LS; Dubitskiĭ AE; Cherviak PI; Furmanenko ED
    Klin Khir (1962); 1988; (11):60. PubMed ID: 2851685
    [No Abstract]   [Full Text] [Related]  

  • 15. Glucagonomas of transgenic mice express a wide range of general neuroendocrine markers and bioactive peptides.
    Rindi G; Efrat S; Ghatei MA; Bloom SR; Solcia E; Polak JM
    Virchows Arch A Pathol Anat Histopathol; 1991; 419(2):115-29. PubMed ID: 1678563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MEN I pancreas: a histological and immunohistochemical study.
    Thompson NW; Lloyd RV; Nishiyama RH; Vinik AI; Strodel WE; Allo MD; Eckhauser FE; Talpos G; Mervak T
    World J Surg; 1984 Aug; 8(4):561-74. PubMed ID: 6207668
    [No Abstract]   [Full Text] [Related]  

  • 17. [Glucagonoma syndrome].
    Tellechea O; Baptista AP
    Acta Med Port; 1988; 1(2):149-52. PubMed ID: 2849866
    [No Abstract]   [Full Text] [Related]  

  • 18. The endocrine pancreas in patients with insulinomas. An immunocytochemical and ultrastructural study of the nontumoral tissue with morphometrical evaluations.
    Bani Sacchi T; Bani D; Biliotti G
    Int J Pancreatol; 1989 Jul; 5(1):11-28. PubMed ID: 2568382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple nonfunctional pancreatic islet cell tumor in multiple endocrine neoplasia type I. A case report.
    Takahashi H; Nakano K; Adachi Y; Aoki N; Hajiro K; Yamamoto T; Higashizawa T; Chikugo T; Suzuki T
    Acta Pathol Jpn; 1988 May; 38(5):667-82. PubMed ID: 2905567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Pathological anatomy of neoplasms of the pancreas. II. Tumors of the endocrine pancreas].
    González Cámpora R; Amérigo Navarro J; Martín Lacave I; Fernández-Novoa MC; Galera H
    Rev Esp Oncol; 1982; 29(1):23-47. PubMed ID: 6322253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.